In this video, trauma surgeon Peter Althausen, M.D., says COVID-19 will shift procedures to outpatient settings and place scrutiny on implant utilization.
Mr. Bihl feels that orthobiologics are in a unique position to address unmet needs that remain prevalent despite advancements in traditional orthopedic products.
First-quarter earnings announcements start in earnest today. We think a clearer picture of the entire orthopedic market could develop in the next month.
Joint replacement surgeon Vinod Dasa, M.D., says there will be a heightened focus on eliminating waste and redundancies, especially in the “last mile” of the supply chain.
While the spine industry has focused on 3D printed cages, enabling technology and minimally invasive surgery, it has forgotten a critical priority: infection prevention, says Aakash Agarwal, Ph.D., Director of Research at Spinal Balance.
Robotic systems would have undoubtedly received major play at the Annual Meeting. We pulled together recent strategic activity to provide greater insight.
In moving to the provider side of orthopedics after spending decades in industry, Doug Leach has learned a valuable lesson: Partner with providers. Not just the surgeon.
Many of the lessons that Tom Afzal has applied throughout his career he learned while working at American Hospital Supply Corporation—one of the largest medical device companies in the ‘70s-‘80s—his first professional position after college. As part of a management path program, Mr. Afzal was required to work in many functional areas of the company—sales, marketing, finance, production, R&D, quality, etc.
Marty Altshuler and Rick Henson were given an opportunity to acquire spinal products and transition from distributorship to a full line implant manufacturing company. They made the deal and founded ChoiceSpine back in 2006.